Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist. 2014 Jun; 19(6):637-8.
-
Jennifer Ang Chan, M.D.
-
James Mark Cleary, Ph.D., M.D.
-
Brian Matthew Wolpin, M.D.
-
Kimmie Ng, M.D.
-
Jeffrey A Meyerhardt, M.D.
-
Douglas Adam Rubinson, M.D., Ph.D.
-
Peter C. Enzinger, M.D.
-
Harvey Jay Mamon, M.D., Ph.D.
-
Nadine Jackson McCleary, M.D.